Kewaunee Scientific Corporation (KEQU) reported mixed results for first-quarter fiscal 2025, with both earnings per share (EPS) and sales declining year over year. The company faced headwinds from delayed international shipments, particularly in India, which weighed on its overall performance. However, domestic operations were stable in the quarter under review, and a growing order backlog suggests the potential for recovery in the coming quarters. Rising costs, driven by higher professional fees, also impa ...